Poorly differentiated neuroendocrine carcinomas of the pancreas: A clinicopathologic analysis of 44 cases Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Neuroendocrine
  • Pancreatic Neoplasms

abstract

  • Poorly differentiated neuroendocrine carcinoma of the pancreas is a highly aggressive neoplasm, with frequent metastases and poor survival. Most patients die within less than a year. Most (61%) are large cell neuroendocrine carcinomas. Well-differentiated NET and acinar cell carcinoma are often misdiagnosed as poorly differentiated neuroendocrine carcinoma, emphasizing that diagnostic criteria need to be clearly followed to ensure accurate diagnosis.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3977000

Digital Object Identifier (DOI)

  • 10.1097/PAS.0000000000000169

PubMed ID

  • 24503751

Additional Document Info

start page

  • 437

end page

  • 47

volume

  • 38

number

  • 4